Deficient nitric oxide signalling impairs skeletal muscle growth and performance: involvement of mitochondrial dysregulation

[1]  Paul L Huang,et al.  Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice. , 2015, Human molecular genetics.

[2]  E. Clementi,et al.  Deficient nitric oxide signalling impairs skeletal muscle growth and performance: involvement of mitochondrial dysregulation , 2014, Skeletal Muscle.

[3]  E. Clementi,et al.  Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers , 2014, Drug design, development and therapy.

[4]  G. Hajnóczky,et al.  Mitochondrial fusion is frequent in skeletal muscle and supports excitation–contraction coupling , 2014, The Journal of cell biology.

[5]  L. Pozzi,et al.  Nitric Oxide Controls Fat Deposition in Dystrophic Skeletal Muscle by Regulating Fibro‐Adipogenic Precursor Differentiation , 2014, Stem cells.

[6]  A. Russell,et al.  Skeletal muscle mitochondria: a major player in exercise, health and disease. , 2014, Biochimica et biophysica acta.

[7]  E. Clementi,et al.  Nitric oxide drives embryonic myogenesis in chicken through the upregulation of myogenic differentiation factors. , 2014, Experimental cell research.

[8]  J. Auwerx,et al.  The mitochondrial unfolded protein response, a conserved stress response pathway with implications in health and disease , 2014, Journal of Experimental Biology.

[9]  G. Thomas.  Functional muscle ischemia in Duchenne and Becker muscular dystrophy , 2013, Front. Physiol..

[10]  E. Clementi,et al.  Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway , 2013, Cell Death and Differentiation.

[11]  S. Schiaffino,et al.  Role of satellite cells in muscle growth and maintenance of muscle mass. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[12]  M. Sandri,et al.  Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies , 2013, Journal of Cell Science.

[13]  Stefano Piccolo,et al.  BMP signaling controls muscle mass , 2013, Nature Genetics.

[14]  M. Sandri,et al.  Mechanisms regulating skeletal muscle growth and atrophy , 2013, The FEBS journal.

[15]  L. Guarente,et al.  The NAD+/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling , 2013, Cell.

[16]  A. Pries,et al.  Phenotype of capillaries in skeletal muscle of nNOS-knockout mice. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[17]  H. Shimokawa,et al.  Nitric oxide synthases and heart failure - lessons from genetically manipulated mice. , 2013, Journal of UOEH.

[18]  A. Musarò,et al.  Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1-Akt-mTOR-FoxO pathway , 2013, Biogerontology.

[19]  E. Clementi,et al.  Autophagy as a new therapeutic target in Duchenne muscular dystrophy , 2013, Cell Death and Disease.

[20]  A. Wagatsuma,et al.  Mitochondria as a Potential Regulator of Myogenesis , 2013, TheScientificWorldJournal.

[21]  Cole M. Haynes,et al.  Signaling the mitochondrial unfolded protein response. , 2013, Biochimica et biophysica acta.

[22]  R. Jacobs,et al.  Mitochondrial function in human skeletal muscle following high‐altitude exposure , 2013, Experimental physiology.

[23]  R. O. Godinho,et al.  Nitric Oxide in Skeletal Muscle: Role on Mitochondrial Biogenesis and Function , 2012, International journal of molecular sciences.

[24]  S. Takeda,et al.  Activation of calcium signaling through Trpv1 by nNOS and peroxynitrite as a key trigger of skeletal muscle hypertrophy , 2012, Nature Medicine.

[25]  J. Tidball,et al.  Age‐related loss of nitric oxide synthase in skeletal muscle causes reductions in calpain S‐nitrosylation that increase myofibril degradation and sarcopenia , 2012, Aging cell.

[26]  P. Gluckman,et al.  The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. , 2012, Cell metabolism.

[27]  D. Serteyn,et al.  Correction: Physical Fitness and Mitochondrial Respiratory Capacity in Horse Skeletal Muscle , 2012, PLoS ONE.

[28]  G. McConell,et al.  Skeletal muscle nitric oxide signaling and exercise: a focus on glucose metabolism. , 2012, American journal of physiology. Endocrinology and metabolism.

[29]  E. Clementi,et al.  Nitric Oxide in Myogenesis and Therapeutic Muscle Repair , 2012, Molecular Neurobiology.

[30]  N. Bresolin,et al.  Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients. , 2012, Pharmacological research.

[31]  E. Clementi,et al.  Nitric Oxide Sustains Long-Term Skeletal Muscle Regeneration by Regulating Fate of Satellite Cells Via Signaling Pathways Requiring Vangl2 and Cyclic GMP , 2011, Stem cells.

[32]  G. McConell,et al.  Early functional muscle regeneration after myotoxic injury in mice is unaffected by nNOS absence. , 2011, American Journal of Physiology. Regulatory Integrative and Comparative Physiology.

[33]  J. Lachey,et al.  Soluble activin receptor type IIB increases forward pulling tension in the mdx mouse , 2011, Muscle & nerve.

[34]  M. Sandri,et al.  Autophagy induction rescues muscular dystrophy , 2011, Autophagy.

[35]  L. Scorrano,et al.  During autophagy mitochondria elongate, are spared from degradation and sustain cell viability , 2011, Nature Cell Biology.

[36]  B. Spiegelman,et al.  The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1α/ATF6α complex. , 2011, Cell metabolism.

[37]  D. Duan,et al.  Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin‐null mice , 2011, Journal of Pathology.

[38]  Cole M. Haynes,et al.  The mitochondrial UPR – protecting organelle protein homeostasis , 2010, Journal of Cell Science.

[39]  N. Maraldi,et al.  Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration , 2010, Nature Medicine.

[40]  Sara E. Miller,et al.  Quantitation of "autophagic flux" in mature skeletal muscle , 2010, Autophagy.

[41]  J. Corbin,et al.  cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action , 2010, Pharmacological Reviews.

[42]  E. Clementi,et al.  Co‐administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans , 2010, British journal of pharmacology.

[43]  P. Codogno,et al.  Overview of macroautophagy regulation in mammalian cells , 2010, Cell Research.

[44]  Luca Scorrano,et al.  Mitochondrial fission and remodelling contributes to muscle atrophy , 2010, The EMBO journal.

[45]  L. Scorrano,et al.  Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation , 2010, Cell Death and Differentiation.

[46]  M. Sandri.  Autophagy in skeletal muscle , 2010, FEBS letters.

[47]  Paul L Huang,et al.  Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle. , 2010, The Journal of clinical investigation.

[48]  Rajvir Singh,et al.  A simple protocol for assessing inter-trial and inter-examiner reliability for two noninvasive measures of limb muscle strength , 2010, Journal of Neuroscience Methods.

[49]  E. Clementi,et al.  Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects. , 2009, Pharmacological research.

[50]  G. Brunelli,et al.  Glutamatergic Reinnervation and Assembly of Glutamatergic Synapses in Adult Rat Skeletal Muscle Occurs at Cholinergic Endplates , 2009, Journal of neuropathology and experimental neurology.

[51]  J. Tidball,et al.  Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy. , 2009, Human molecular genetics.

[52]  E. Clementi,et al.  Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wasting , 2009, Journal of Cell Science.

[53]  A. Nishiyama,et al.  The opposite roles of nNOS in cardiac ischemia–reperfusion-induced injury and in ischemia preconditioning-induced cardioprotection in mice , 2009, The Journal of Physiological Sciences.

[54]  J. Chamberlain,et al.  Functional Deficits in nNOSμ-Deficient Skeletal Muscle: Myopathy in nNOS Knockout Mice , 2008, PloS one.

[55]  D. Thedens,et al.  Sarcolemma-localized nNOS is required to maintain activity after mild exercise , 2008, Nature.

[56]  R. Margreiter,et al.  Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells , 2008, Nature Protocols.

[57]  A. Goldberg,et al.  FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.

[58]  E. Clementi,et al.  Necdin mediates skeletal muscle regeneration by promoting myoblast survival and differentiation , 2007, The Journal of cell biology.

[59]  Y. Itoyama,et al.  NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. , 2007, The Journal of clinical investigation.

[60]  E. Clementi,et al.  Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma. , 2007, Cancer research.

[61]  Nathan H. Lents,et al.  XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. , 2007, Molecular cell.

[62]  F. Dini,et al.  Molecular mechanisms of euplotin C-induced apoptosis: involvement of mitochondrial dysfunction, oxidative stress and proteases , 2007, Apoptosis.

[63]  A. Balbarini,et al.  Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages , 2007, Journal of leukocyte biology.

[64]  E. Clementi,et al.  Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy , 2007, Proceedings of the National Academy of Sciences.

[65]  E. Clementi,et al.  Nitric oxide and mitochondrial biogenesis: a key to long-term regulation of cellular metabolism. , 2005, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[66]  E. Clementi,et al.  Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[67]  E. Clementi,et al.  Activation of Acid Sphingomyelinase and Its Inhibition by the Nitric Oxide/Cyclic Guanosine 3′,5′-Monophosphate Pathway: Key Events in Escherichia coli-Elicited Apoptosis of Dendritic Cells1 , 2004, The Journal of Immunology.

[68]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[69]  J. Stamler,et al.  Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[70]  J. Tidball,et al.  Expression of a muscle‐specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation during modified muscle use in mice , 2003, The Journal of physiology.

[71]  E. Clementi,et al.  Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide , 2003, Science.

[72]  K. Campbell,et al.  Loss of sarcolemma nNOS in sarcoglycan‐deficient muscle , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[73]  M. Ryan,et al.  A mitochondrial specific stress response in mammalian cells , 2002, The EMBO journal.

[74]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[75]  J. Tidball,et al.  A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice , 2001, The Journal of cell biology.

[76]  E. Clementi,et al.  Nitric Oxide Inhibits the Tumor Necrosis Factor α-regulated Endocytosis of Human Dendritic Cells in a Cyclic GMP-dependent Way* , 2000, The Journal of Biological Chemistry.

[77]  A. Serdaroğlu,et al.  The serum nitric oxide levels in patients with Duchenne muscular dystrophy , 2000, Brain and Development.

[78]  J. E. Anderson,et al.  A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. , 2000, Molecular biology of the cell.

[79]  E. Clementi,et al.  On the mechanism by which vascular endothelial cells regulate their oxygen consumption. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[80]  D. Bredt.  NO skeletal muscle derived relaxing factor in Duchenne muscular dystrophy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[81]  P. Huang,et al.  Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[82]  D. Bredt,et al.  Muscular Dystrophy in mdx Mice Despite Lack of Neuronal Nitric Oxide Synthase , 1998, Journal of neurochemistry.

[83]  K. Campbell,et al.  mdx muscle pathology is independent of nNOS perturbation. , 1998, Human molecular genetics.

[84]  Z. Abassi,et al.  Involvement of nitric oxide system in experimental muscle crush injury. , 1998, The Journal of clinical investigation.

[85]  D. Bredt,et al.  Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy , 1996, The Journal of experimental medicine.

[86]  E. Clementi,et al.  Growth factor-induced Ca2+ responses are differentially modulated by nitric oxide via activation of a cyclic GMP-dependent pathway. , 1995, Molecular pharmacology.

[87]  K. Aldape,et al.  Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy , 1995, Cell.

[88]  S. Moncada,et al.  Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide , 1994, FEBS letters.

[89]  E. Clementi,et al.  The thyroid hormone triiodothyronine controls macrophage maturation and functions: protective role during inflammation. , 2014, The American journal of pathology.

[90]  C. Fader,et al.  Autophagy and multivesicular bodies: two closely related partners , 2009, Cell Death and Differentiation.

[91]  D. Leroith,et al.  Skeletal muscle. , 2005, Advances in experimental medicine and biology.

[92]  M. Miura,et al.  A transgenic mouse model for monitoring endoplasmic reticulum stress , 2004, Nature Medicine.

[93]  J. Stamler,et al.  Physiology of nitric oxide in skeletal muscle. , 2001, Physiological reviews.

[94]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.

[95]  S. Gross,et al.  Nitric oxide: pathophysiological mechanisms. , 1995, Annual review of physiology.

[96]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .